Cleveland neurotechnology device company NeuroWave Systems is ramping up its global marketing efforts by releasing the next-generation version of its flagship anesthesia-monitoring device in Canada and Europe.The new model of the NeuroSENSE Monitor, which uses an algorithm to help doctors tailor the amount of anesthesia patients need by displaying and interpreting electroencephalogram (EEG) signals from [...]

Medical device startup NeuroWave Systems Inc. has reached a deal in which CareFusion (NYSE: CFN) will distribute NeuroWave’s brain-activity monitoring system in Germany and Scandinavia. It’s an important step for Cleveland Heights, Ohio-based NeuroWave, which in June received European regulatory clearance to begin selling its NeuroSense brain monitor for assessing anesthesia levels.

Medical device startup NeuroWave Systems Inc. has received regulatory clearance from the Food and Drug Administration to begin selling a brain-activity monitoring system. The Cleveland Heights, Ohio-based company’s NeuroFAST Monitoring System is intended for use in hospital operating rooms, emergency departments and intensive care units with patients who’ve experienced some sort of brain trauma, such as seizures.

Bob Schmidt thinks he has an answer for the mega trends of rising healthcare costs, fewer doctors to treat more patients, and provider pay-cuts by the federal government: eHealth. And for Schmidt’s Cleveland Medical Devices (CleveMed), eHealth means dreaming up diagnostic devices for sleep and movement disorders that can cut up to 90 percent of the cost of traditional tests — and even help primary care physicians find new revenue sources.

BioOhio and LifeScience Alley, the state biotechnology development organizations in Ohio and Minnesota, have joined 20 other industry associations asking legislators to limit the medical device taxes or fees proposed in both the House and Senate versions of health care reform.

The clearance designations are “a big deal” to the company because they could help it double sales in the next two years, said Chief Executive Bob Schmidt.